GABRIELLE VENTURA: Open Payments
NPI 1831827401 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 37 payments from 14 companies in 2025. Trend: 2023 $897 · 2024 $691 · 2025 $796
Food & beverage: $717Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $157 |
| ABBVIE INC. | 8 | $145 |
| Lilly USA, LLC | 4 | $66 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Ardelyx, Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: TREMFYA, ENTYVIO, OMVOH, LINZESS, REZDIFFRA, RINVOQ, DUPIXENT, CREON.
Industry payments across NC — which companies pay providers there.
